Table 4 Started postoperative chemotherapy stage II-III
Stage II | Stage III | |||
|---|---|---|---|---|
Low risk (%) | High risk (%) | N1 (%) | N2 (%) | |
Colon cancer | 107 | 539 | 1425 | 1088 |
Capecitabine/5-FU | 51 (47.7) | 296 (54.9) | 662 (46.4) | 336 (30.9) |
Capecitabine/5-FU+ | 42 (39.2) | 209 (38.8) | 693 (48.6) | 689(63.3) |
Oxaliplatin | ||||
Other combinations | 14 (13.1) | 34 (6.3) | 70 (4.9) | 63 (5.8) |
Rectal cancer | 135 | 258 | 556 | 471 |
Capecitabine/5-FU | 72 (53.3) | 142 (55.0) | 294 (52.9) | 168 (35.7) |
Capecitabine/5-FU+ | 33 (24.4) | 66 (25.6) | 203 (36.5) | 245 (52.0) |
Oxaliplatin | ||||
Other combinations | 28 (20.7) | 50 (19.4) | 59 (10.6) | 58 (12.3) |